Download PDF
Synlett 2008(19): 2961-2964  
DOI: 10.1055/s-0028-1083626
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

N-Heterocyclic Carbenes of Indazole as Reagents: Indazol-3-ylidene-Mediated Syntheses of Amidines from Thiolactams of Pyrrolobenzodiazepines

Anika Lindner, Andreas Schmidt*
Institute of Organic Chemistry, Clausthal University of Technology, Leibnizstr. 6, 38678 Clausthal-Zellerfeld, Germany
Fax: +49(5323)723861; e-Mail: schmidt@ioc.tu-clausthal.de;
Further Information

Publication History

Received 5 August 2008
Publication Date:
12 November 2008 (online)

    Permissions and Reprints All articles of this category

Abstract

On decarboxylation, 1,2-dimethylindazolium-3-carboxylate forms in situ the N-heterocyclic carbene 1,2-dimethylindazol-3-ylidene, which proved to be a suitable reagent for amidinations of the monothiolactam of benzo[e]pyrrolo[1,2-a][1,4]diazepine. A comparison of this metal-free approach to amidines to HgCl2- and Bi(NO3)3-mediated reactions is presented.

Key Words

thiolactam - bismuth(III) nitrate - mercury(II) chloride - mesomeric betaine - decarboxylation

    References and Notes

  • 1 Jagodziñski TS. Chem. Rev.  2003,  103:  197 
    CrossrefGoogle Scholar
  • 2a Lebel H. In Science of Synthesis   Vol. 22:  Charette AB. Thieme; Stuttgart: 2005.  p.141-179  
    Google Scholar
  • 2b Schaumann E. In Comprehensive Organic Synthesis   Vol. 6:  Trost BM. Fleming I. Pergamon; Oxford: 1991.  p.419-434  
    Google Scholar
  • 2c Bauer W. Kühlein K. In Methoden der Organischen Chemie (Houben-Weyl)   Vol. E5:  Thieme; Stuttgart: 1985.  p.1218-1279  
    Google Scholar
  • 2d Cava MP. Levinson MI. Tetrahedron  1985,  41:  5061 
    Google Scholar
  • 2e Hurd RN. Delamater G. Chem. Rev.  1961,  61:  45 
    Google Scholar
  • 2f Jagodziński TS. Org. Prep. Proced. Int.  1990,  22:  755 
    Google Scholar
  • 3 Ostrowska K. Kolasa A. In Science of Synthesis   Vol. 22:  Charette AB. Thieme; Stuttgart: 2005.  p.429 
    Google Scholar
  • 4 Al Ashry SH. Abdel-Rahman AA.-H. El Kilany Y. Schmidt RR. Tetrahedron  1999,  55:  2381 
    CrossrefGoogle Scholar
  • 5a Barker PL. Gendler PL. Rapoport H. J. Org. Chem.  1981,  46:  2455 
    Google Scholar
  • 5b Stanek J. Caravatti G. Capraro H.-G. Furet P. Mett H. Schneider P. Regenass U. J. Med. Chem.  1993,  36:  46 
    Google Scholar
  • 6 Nii Y. Okano K. Kobayashi S. Ohno M. Tetrahedron Lett.  1979,  2517 
    CrossrefGoogle Scholar
  • 7 Nakayama Y. Senokuchi K. Sakaki K. Kato M. Maruyama T. Miyazaki T. Ito H. Nakai H. Kawamura M. Bioorg. Med. Chem.  1997,  5:  971 
    CrossrefGoogle Scholar
  • 8 Avalos M. Babiano R. Cintas P. Durán CJ. Jiménez JL. Palacios JC. Tetrahedron  1995,  51:  8043 
    CrossrefGoogle Scholar
  • 9a Foloppe MP. Rault S. Thurston DE. Jenkins TC. Robba M. Eur. J. Med. Chem.  1996,  407 
    Google Scholar
  • 9b Suzuki K. Fujii T. Sato K.-I. Hashimoto H. Tetrahedron Lett.  1996,  37:  5921 
    Google Scholar
  • 9c Barin CT. Brunton SA. Tetrahedron Lett.  2002,  43:  1893 
    Google Scholar
  • 10a Dobashi Y. Kobayashi K. Dobashi A. Tetrahedron Lett.  1998,  39:  93 
    Google Scholar
  • 10b Panday N. Vasella A. Synthesis  1999,  1459 
    Google Scholar
  • 11 Marchand-Brynaert J. Moya-Portuguez M. Huber I. Ghosez L. J. Chem. Soc., Chem. Commun.  1983,  818 
    CrossrefGoogle Scholar
  • 12a Da Settimo F. Taliani S. Trincavelli ML. Montali M. Martini C. Curr. Med. Chem.  2007,  14:  2680 
    Google Scholar
  • 12b Lueddens H. Korpi ER. Handbook of Contemporary Neuropharmacology   Vol. 2:  Wiley; Hoboken: 2007.  p.93 
    Google Scholar
  • 12c Bacon ER. Chatterjee S. Williams M. Comprehensive Medicinal Chemistry. II   Vol. 6:  Elsevier; Oxford: 2006.  p.139 
    Google Scholar
  • 13 Herpin TF. Van Kirk KG. Salvino JM. Yu ST. Labaudiniere RF. J. Comb. Chem.  2000,  2:  513 
    CrossrefPubMedGoogle Scholar
  • 14a Kamal A. Khan MNA. Reddy KS. Ahmed SK. Kumar MS. Juvekar A. Sen S. Zingde S. Bioorg. Med. Chem. Lett.  2007,  17:  5345 
    Google Scholar
  • 14b Antonow D. Cooper N. Howard PW. Thurston DE. J. Comb. Chem.  2007,  9:  437 
    Google Scholar
  • 14c Kamal A. Reddy DR. Reddy PSMM. Bioorg. Med. Chem. Lett.  2007,  17:  803 
    Google Scholar
  • 14d Kamal A. Shankaraiah N. Devaiah V. Reddy KL. Tetrahedron Lett.  2006,  47:  6553 
    Google Scholar
  • 14e Kang G.-D. Howard PW. Thurston DE. Chem. Commun.  2003,  1688 
    Google Scholar
  • 14f Cooper N. Hagan DR. Tiberghien A. Ademefun T. Matthews CS. Howard PW. Thurston DE. Chem. Commun.  2002,  1764 
    Google Scholar
  • 14g Kamal A. Ramu R. Khanna GBR. Saxena AK. Shanmugavel M. Pandita RM. Arkivoc  2005,  (iii):  83 
    Google Scholar
  • 14h Hurley LH. Boyed FL. Trends Pharmacol. Sci.  1988,  9:  402 
    Google Scholar
  • 14i Zhilina ZV. Ziemba AJ. Trent JO. Reed MW. Gorn V. Zhov Q. Duan W. Hurley L. Ebbinghaus SW. Bioconjugate Chem.  2004,  15:  1182 
    Google Scholar
  • 14j Kumar R. Lown JW. Mini-Rev. Med. Chem.  2003,  3:  323 
    Google Scholar
  • 15 Dervan PB. Science  1986,  232:  464 
    CrossrefGoogle Scholar
  • 16a Leimgruber W. Stefanovic V. Schenker F. Karr A. Berger J. J. Am. Chem. Soc.  1965,  87:  5791 
    Google Scholar
  • 16b Leimgruber W. Batcho AD. Schenker F. J. Am. Chem. Soc.  1965,  87:  5793 
    Google Scholar
  • 16c Arora SK. Acta Crystallogr., Sect. B:  1979,  35:  2945 
    Google Scholar
  • 17a Arima K. Kohsaka M. Tamura J. Imanaka H. Sakai H. J. Antibiot.  1972,  25:  437 
    Google Scholar
  • 17b Nishioka Y. Beppu T. Kohsaka M. Arima K. J. Antibiot.  1972,  25:  660 
    Google Scholar
  • 17c Tazuka Z. Takaya T. J. Antibiot.  1983,  36:  142 
    Google Scholar
  • 18 Hochlowski JE. Andres WW. Theriault RJ. Jackson M. McAlpine JB. J. Antibiot.  1987,  40:  145 
    Google Scholar
  • 19 Konishi M. Ohkuma H. Naruse N. Kawaguchi H. J. Antibiot.  1984,  37:  200 
    Google Scholar
  • 20 Kyowa Hakko Kogyo Co. Ltd . inventors; JP  58180487.  ; Chem. Abstr. 1984, 100, 173150
  • 21 Kunimoto S. Masuda T. Kanbayashi N. Hamada M. Naganawa H. Miamota M. Takeuchi T. Umezawa H. J. Antibiot.  1980,  33:  665 
    Google Scholar
  • 22a Takeuchi T. Miamota M. Ishizuka M. Naganawa H. Kondo S. Hamada M. Umezawa H. J. Antibiot.  1976,  29:  93 
    Google Scholar
  • 22b Miyamoto M. Kondo S. Naganawa H. Maeda K. Ohno M. Umezawa H. J. Antibiot.  1977,  30:  340 
    Google Scholar
  • 23 Shimizu K.-I. Kawamoto I. Tomita F. Morimoto M. Fujimoto K. J. Antibiot.  1982,  35:  972 
    Google Scholar
  • 24a Hara M. Tamaoki T. Yoshida M. Morimoto M. Nakano H. J. Antibiot.  1988,  51:  702 
    Google Scholar
  • 24b Itoh J. Watabe H.-O. Ishii S. Gomi S. Nagasawa M. Yamamoto H. Shomura T. Sezaki M. Kondo S. J. Antibiot.  1988,  41:  1281 
    Google Scholar
  • 25 Leber JD. Hoover JRE. Holden KG. Johnson RK. Hecht SM. J. Am. Chem. Soc.  1988,  110:  2992 
    CrossrefGoogle Scholar
  • 26 Tsunkawa M. Kamei H. Konishi M. Miyaki T. Oki T. Kawakuchi H. J. Antibiot.  1988,  41:  1366 
    CrossrefGoogle Scholar
  • 27 Rahbaek L. Breinhold J. Frisvad JC. Christophersen C. J. Org. Chem.  1999,  64:  1689 
    CrossrefPubMedGoogle Scholar
  • 28a Schmidt A. Beutler A. Habeck T. Mordhorst T. Snovydovych B. Synthesis  2006,  1882 
    Google Scholar
  • 28b Schmidt A. Snovydovych B. Habeck T. Dröttboom P. Gjikaj M. Adam A. Eur. J. Org. Chem.  2007,  4909 
    Google Scholar
  • 28c Schmidt A. Merkel L. Eisfeld W. Eur. J. Org. Chem.  2005,  2124 
    Google Scholar
  • 29 Schmidt A. Habeck T. Snovydovych B. Eisfeld W. Org. Lett.  2007,  9:  3515 
    CrossrefPubMedGoogle Scholar
  • 30 Schmidt A. Snovydovych B. Synthesis  2008,  2798 
    Article in Thieme ConnectGoogle Scholar
  • 31 Schmidt A. Snovydovych B. Hemmen S. Eur. J. Org. Chem.  2008,  4313 
    CrossrefGoogle Scholar
  • 32 Kamal A. Howard PW. Reddy BSN. Reddy BSP. Thurston DE. Tetrahedron  1997,  53:  3223 
    CrossrefGoogle Scholar
  • 34a Foloppe MP. Rault S. Robba M. Tetrahedron Lett.  1992,  33:  2803 
    Google Scholar
  • 34b Foloppe MP. Rault I. Rault S. Robba M. Heterocycles  1993,  36:  63 
    Google Scholar
  • 34c Gillard A.-C. Rault S. J. Heterocycl. Chem.  1997,  34:  1185 
    Google Scholar
  • 35 Cunha S. de Lima BR. de Souza AR. Tetrahedron Lett.  2002,  43:  49 
    CrossrefGoogle Scholar
  • 37 Schmidt A. Gholipour Shilabin A. Namyslo JC. Nieger M. Hemmen S. Eur. J. Org. Chem.  2005,  1781 
    Google Scholar
  • 38a Schmidt A. Gholipour Shilabin A. Nieger M. Heterocycles  2004,  63:  2851 
    Google Scholar
  • 38b Schmidt A. Gholipour Shilabin A. Nieger M. Heterocycles  2005,  65:  625 
    Google Scholar
  • 38c Schmidt A. Lindner AS. Gholipour Shilabin A. Nieger M. Tetrahedron  2008,  64:  2048 
    Google Scholar
  • 39 Gillard A.-C. Foloppe M.-P. Rault S. J. Heterocycl. Chem.  1997,  34:  445 
    CrossrefGoogle Scholar
33

General Procedure for the Synthesis of ( S )-11-(Butyl-amino)-2,3-dihydro-1 H -benzo[ e ]pyrrolo[1,2- a ][1,4]-diazepin-5-(11a H )-one (5a)
Method A
Thiolactam (4, 0.232 g, 1 mmol) was suspended in n-BuNH2 (4 mL) and heated to 60 ˚C. At this temperature HgCl2 (0.272 g, 1 mmol) was added, and the mixture was heated over a period of 1 h at reflux temperature. After cooling, the reaction mixture was filtered through a plug of Celite and washed with CHCl3. The filtrate was washed with aq Na2S2O3 and dried over Na2SO4. The solvent and excess amine were distilled off in vacuo. The residue was then chromatographed (SiO2, PE-EtOAc, 1:5).
Method B
Bi(NO3)3 (0.395 g, 1 mmol) was used.
Method C
Compound 1 (0.190 g, 1 mmol) was used and heated as described. Then, the reaction mixture was concentrated in vacuo and chromatographed. The amidine was obtained as a faintly yellow oil, respectively; [α]D 518 (c 1, CDCl3). ¹H NMR (200 MHz, CDCl3): δ = 0.96 (t, J = 7.17 Hz, 3 H,
16-H), 1.31-1.49 (m, 2 H, 15-H), 1.54-1.69 (m, 2 H, 14-H), 2.00-2.14 (m, 3 H, 1-H, 2-H), 2.18-2.30 (m, 1 H, 1-H), 3.34-3.48 (m, 2 H, 13-H), 3.51-3.64 (m, 1 H, 3-H), 3.82-3.94 (m, 1 H, 3-H), 4.02 (t, J = 4.93 Hz, 1 H, 11a-H), 4.76 (br s, 1 H, NH), 7.02-7.14 (m, 2 H, 7-H, 9-H), 7.35-7.44 (m, 1 H, 8-H), 7.93 (dd, J = 7.9, 1.4 Hz, 1 H, 6-H). ¹³C NMR (50 MHz, CDCl3): δ = 13.9 (C-16), 20.3 (C-15), 23.8 (C-2), 26.7 (C-1), 31.1 (C-14), 41.2 (C-13), 46.3 (C-3), 54.3 (C-11a), 122.1, 126.4, 126.8, 129.9, 131.5, 147.4, (6C, Carom.), 156.1 (C-11), 166.7 (C=O). IR (KBr) = 3345, 3057, 2956, 2871, 1607, 1536, 1456, 1412, 1337, 1236, 1202, 1148, 1034, 835, 762 cm-¹. MS (EI): m/z (%) = 271 (80) [M+], 242 (20), 229 (20), 215 (10), 199 (15), 187 (25), 173 (30), 160 (70), 146 (30), 119 (25), 90 (30), 70 (100). Anal. Calcd for C16H21N3O: C, 70.82; H, 7.80; N, 15.49. Found: C,70.58; H, 7.41; N, 14.91.

36

Compound 5g exists as mixture of tautomers A and B in DMSO-d 6; a single-crystal X-ray structure analysis was performed of tautomer B.³7